FDA to Consider Over-Counter Sale of Morning-After Pill
The government agency will weigh whether to let the drug (Plan B) be sold over the counter — a move that conservative forces, inside the government and out, have long objected to as part of their proxy battle on abortion. This may be happening only because two senators have been blocking the appointment of the FDA’s new head until the agency makes a decision on the drug.
Wait, before you go…
The Food and Drug Administration said today it is considering approval of the morning-after pill for sale without a prescription, a surprise move on an issue that has ensnared the agency in debate for years.
Discussions between the government and Barr Laboratories, which manufactures the drug, known as Plan B, are set to begin immediately and could be completed ?in a matter of weeks,? the agency said in a statement.
The move could end a standoff between the Bush administration and Democrats on Capitol Hill.
If you're reading this, you probably already know that non-profit, independent journalism is under threat worldwide. Independent news sites are overshadowed by larger heavily funded mainstream media that inundate us with hype and noise that barely scratch the surface. We believe that our readers deserve to know the full story. Truthdig writers bravely dig beneath the headlines to give you thought-provoking, investigative reporting and analysis that tells you what’s really happening and who’s rolling up their sleeves to do something about it.
Like you, we believe a well-informed public that doesn’t have blind faith in the status quo can help change the world. Your contribution of as little as $5 monthly or $35 annually will make you a groundbreaking member and lays the foundation of our work.Support Truthdig
There are currently no responses to this article.
Be the first to respond.